[1]. Zhu, L., Luo, M., Zhang, Y., Fang, F., Li, M., An, F., ... & Zhang, J. (2023). Free radical as a double-edged sword in disease: Deriving strategic opportunities for nanotherapeutics. Coordination Chemistry Reviews, 475, 214875.
[2]. Alotibi, M. N., Alnoury, A. M., & Alhozali, A. M. (2019). Serum nesfatin-1 and galanin concentrations in the adult with metabolic syndrome: relationships to insulin resistance and obesity. Saudi medical journal, 40(1), 19.
[3]. Fang, P., Yu, M., Shi, M., Bo, P., & Zhang, Z. (2020). Galanin peptide family regulation of glucose metabolism. Frontiers in Neuroendocrinology, 56, 100801.
[4]. Acar, S., Paketci, A., Küme, T., Demir, K., Çalan, Ö. G., Böber, E., & Abaci, A. (2018). Positive correlation of galanin with insulin resistance and triglyceride levels in obesechildren. Turkish journal of medical sciences, 48(3), 560-568.
[5]. Fang, P., She, Y., Han, L., Wan, S., Shang, W., Zhang, Z., & Min, W. (2021). A promising biomarker of elevated galanin level in hypothalamus for osteoporosis risk in type 2 diabetes mellitus. Mechanisms of Ageing and Development, 194, 111427.
[6]. Aldulimy, B. H. A, Alaaraji, S. F. T. (2021) Study the Association of β-Salusin with some Anthropometric Measurements in Iraqi Type II Diabetics Women. Egyptian Journal of Chemistry 64 (11), 6515-6522.
[7]. Fayez, S. S., Rashied, M. R. , Shakir F.T. Al-Alaaraji, S.F. T. (2020). Evaluation of Serum Clusterin Levels in Type 2 Diabetic Men with and without Cardiovascular Disease. Iraqi Journal of Science, 61 (5), 978-984.
[8]. Idelevich, A., Sato, K., Nagano, K., Rowe, G., Gori, F., Baron, R., 2018. Neuronal hypothalamic regulation of body metabolism and bone density is galanin dependent. J. Clin. Invest. 128 (6), 2626–2641.
[9]. McDonald, A.C., Schuijers, J.A., Gundlach, A.L., Grills, B.L., 2007. Galanin treatment offsets the inhibition of bone formation and downregulates the increase in mouse calvarial expression of TNFalpha and GalR2 mRNA induced by chronic daily injections of an injurious vehicle. Bone. 40, 895–903.
[10]. Idelevich, A., Sato, K., Nagano, K., Rowe, G., Gori, F., Baron, R., 2019. ΔFosB requires
galanin, but not leptin, to increase bone mass via the hypothalamus, but both are needed to increase energy expenditure. J. Bone Miner. Res. 34 (9), 1707–1720.
[11]. Le Bu, Q. Y., Liu, Z., Tang, W., Zou, J., & Qu, S. (2014). Combined galanin with insulin improves insulin sensitivity of diabetic rat muscles. Journal of Endocrinology, 221, 157-165.
[12]. Uygur, F. A., Dişçi, E., Peksöz, R., Öztürk, N., Yildirgan, M. İ., & Albayrak, Y. (2022). Diagnostic value of serum levels of galanin and obestatin in patients with gastric cancer. Revista da Associação Médica Brasileira, 68, 888-892.
[13]. Szeliga, A., Rudnicka, E., Maciejewska-Jeske, M., Kucharski, M., Kostrzak, A., Hajbos, M., ... & Meczekalski, B. (2022). Neuroendocrine determinants of polycystic ovary syndrome. International Journal of Environmental Research and Public Health, 19(5), 3089.
[14]. Zhang, Z., Fang, P., Shi, M., Gu, C., Wang, Y., Bo, P., & Zhu, Y. (2015). Association between circulating levels of galanin and pre-pregnancy body mass index in patients with gestational diabetes mellitus. Eating behaviors, 19, 57-60.
[15]. Fang, P., Shi, M., Zhu, Y., Bo, P., & Zhang, Z. (2016). Type 2 diabetes mellitus as a disorder of galanin resistance. Experimental gerontology, 73, 72-77.
[16]. Simons, P. I., Valkenburg, O., van de Waarenburg, M. P., van Greevenbroek, M. M., Kooi, M. E., Jansen, J. F., ... & Brouwers, M. C. (2023). Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study. Diabetologia, 66(1), 213-222.
[17]. Thye C. K, Lee Y. W, Jalalonmuhali M, et al. (2022). The Utility of Combined Urine Urea and Creatinine Clearance for Pretransplant Renal Function Assessment. Transplantation Proceedings. In Press. Available online 3 February 2022.
[18]. Liu, F., Ma, G., Tong, C., Zhang, S., Yang, X., Xu, C., ... & Li, M. (2022). Elevated blood urea nitrogen-to-creatinine ratio increased the risk of Coronary Artery Disease in patients living with type 2 diabetes mellitus. BMC Endocrine Disorders, 22(1), 50.
[19]. Bilgin, S., Kurtkulagi, O., Tel, B. M. A., Duman, T. T., Kahveci, G., Khalid, A., & Aktas, G. (2021). Does C-reactive protein to serum Albumin Ratio correlate with diabEtic nephropathy in patients with Type 2 dIabetes MEllitus? The CARE TIME study. Primary Care Diabetes, 15(6), 1071-1074.
[20]. Zong, J., Sun, Y., Zhang, Y., Yuan, J., Wang, X., Zhang, R., ... & Gu, Y. (2020). Correlation between serum uric acid level and central body fat distribution in patients with type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 13, 2521.
[21]. Mukhtar, Y., Galalain, A., & Yunusa, U. (2020). A modern overview on diabetes mellitus: a chronic endocrine disorder. European Journal of Biology, 5(2), 1-14.
[22]. Bu, L., Yao, Q., Liu, Z., Tang, W., Zou, J., Qu, S., 2014. Combined galanin with insulin
improves insulin sensitivity of diabetic rat muscles. J. Endocrinol. 221, 157-165.
[23]. Zhang, Z., Gu, C., Fang, P., Shi, M., Wang, Y., Peng, Y., 2014. Endogenous galanin as a
novel biomarker to predict gestational diabetes mellitus. Peptides 54, 186-189.
[24]. Alotibi, M. N., Alnoury, A. M., & Alhozali, A. M. (2019). Serum nesfatin-1 and galanin concentrations in the adult with metabolic syndrome: relationships to insulin resistance and obesity. Saudi medical journal, 40(1), 19.
[25]. Khadanga, S., Barrett, K., Sheahan, K. H., & Savage, P. D. (2023). Novel Therapeutics for Type 2 Diabetes, Obesity, and Heart Failure: A REVIEW AND PRACTICAL RECOMMENDATIONS FOR CARDIAC REHABILITATION. Journal of Cardiopulmonary Rehabilitation and Prevention, 43(1), 1-7.
)
